No Data
Zhitoon Hong Kong stocks interpretation | The Federal Reserve agreed to cut interest rates by 25 basis points, with strong financial reports from leading companies driving the collective growth.
Yesterday, the sluggish performance of internet-related giants caused the Hang Seng Index to stagnate. Today, the situation quickly reversed as the financial reports of several major giants were strong, resulting in across-the-board increases.
Citi Reaffirms Their Buy Rating on JD (JD)
JD Health (06618) rose 5.2% after the performance report, with a more than 30% year-on-year increase in net profit for the first half of the year via Hong Kong Connect.
Jd Health (06618) stock price has risen by 5.2% to HKD 20.85 as of press time, with a turnover of HKD 94.9786 million. The company recently released its 2024 midterm performance report. The financial report shows a net profit attributable to owners of the company of CNY 2.037 billion, a year-on-year increase of 30.48%; revenue of CNY 28.344 billion, a year-on-year increase of 4.55%; basic earnings per share of CNY 0.65. Among them, commodity revenue was CNY 23.91 billion, up 3.2% year-on-year. The main drivers of the growth in commodity revenue are the increase in active users and
Guolonghui Announcement Selection (HK Stock) | Alibaba's first financial report of the new fiscal year: strategic investment is effective, Taotian market share is stable, and Alibaba Cloud is accelerating growth.
Alibaba's first quarter financial report for the new fiscal year: Strategic investment pays off, Taotian market share stabilizes, and Alibaba Cloud accelerates growth. On the evening of August 15th, Alibaba Group announced its performance for the first quarter of 2025 fiscal year, focusing on strategic goals and continuing to invest to achieve positive progress in its two core businesses: e-commerce and cloud computing. Taotian Group's online GMV maintains steady growth, and Alibaba Cloud focuses on "public cloud+AI", with double-digit growth in public cloud revenue and triple-digit growth in AI-related product revenue. "This quarter's performance shows that our strategy is effective. We focus on improving the user experience through good products, good prices, and good services, driving growth for Taotian Group."
JD Health's H1 Profit Surges to 2 Billion Yuan
JD Health (06618): Liao Jiajie is appointed as an independent non-executive director.
JD Health (06618) announced that Professor Liao Jiajie has been appointed as an independent non-executive director, effective from August 2024...
No Data
